This is achieved by giving extra insulin, carbohydrates to stop low blood sugars from the insulin injections and fluids to flush the ketones produced from fat breakdown out of the body
For women navigating perimenopause or menopause, microdosing GLP-1 for menopause symptoms represents a potential tool for addressing metabolic changes during this transition
Long-acting injectables provide a steady supply of insulin throughout the week, which helps to control blood sugar levels and appetite
Conclusion In this article, we have explored the connection between semaglutide and fast heart rate, a potential side effect that can be concerning for patients using this medication
For semaglutide, microdosing might mean starting at 0.1 mg weekly instead of 0.25 mg, or staying at 0.25 mg for 8 weeks instead of 4 before escalating
This means the weight loss seen was not due to chance